Hormone receptors in malignancy (Q35228457)

7 August 2017

1 reference

title

Hormone receptors in malignancy (English)

1 reference

7 August 2017

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

4 December 2023

author name string

Danforth DN Jr

1

1 reference

7 August 2017

D. N. Danforth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1317180

12 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1317180

12 September 2022

publication date

1 March 1992

1 reference

full work available at URL

7 August 2017

https://api.elsevier.com/content/article/PII:1040842892900866?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

https://api.elsevier.com/content/article/PII:1040842892900866?httpAccept=text/plain

4 December 2023

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Critical Reviews in Oncology Hematology

4 December 2023

published in

1 reference

7 August 2017

volume

12

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

91-149

1 reference

Inhibition of human mammary and prostatic cancers by adrenalectomy

7 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Hormone receptor assays: clinical usefulness in the management of carcinoma of the breast

4 December 2023

2

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Laboratory analyses for steroid hormone receptors, and their applications to clinical medicine

4 December 2023

3

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The steroid and thyroid hormone receptor superfamily

4 December 2023

6

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The steroid receptor superfamily: more excitement predicted for the future

4 December 2023

7

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Isolation and characterization of human TR3 receptor: a member of steroid receptor superfamily

4 December 2023

8

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Molecular cloning of new human TR2 receptors: a class of steroid receptor with multiple ligand-binding domains

4 December 2023

9

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers

4 December 2023

11

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Structure and dynamics of the estrogen receptor

4 December 2023

12

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate

4 December 2023

13

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Dopamine activation of an orphan of the steroid receptor superfamily

4 December 2023

16

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Variant human breast tumor estrogen receptor with constitutive transcriptional activity

4 December 2023

17

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Localization of the human oestrogen receptor gene to chromosome 6q24----q27 by in situ hybridization

4 December 2023

18

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A

4 December 2023

19

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Sequence and expression of human estrogen receptor complementary DNA

4 December 2023

20

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen

4 December 2023

21

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo

4 December 2023

22

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Comparative binding affinity of estrogens and its relation to estrogenic potency

4 December 2023

23

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Kinetic Alterations in Estrogen Receptors Associated with Estrogen Receptor Processing in Human Breast Cancer Cells*

4 December 2023

24

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Reconstitution of the 9 S estrogen receptor with heat shock protein 90

4 December 2023

29

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Reduced levels of hsp90 compromise steroid receptor action in vivo

4 December 2023

31

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Mechanisms of action of steroid receptors in the regulation of gene transcription

4 December 2023

32

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Gene regulation by steroid hormones

4 December 2023

34

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Solution structure of the DNA-binding domain of the oestrogen receptor

4 December 2023

35

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model

4 December 2023

36

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor

4 December 2023

37

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

A 22-amino-acid peptide restores DNA-binding activity to dimerization-defective mutants of the estrogen receptor

4 December 2023

38

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The human estrogen receptor has two independent nonacidic transcriptional activation functions

4 December 2023

39

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor

4 December 2023

40

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid hormone action in eucaryotic cells

4 December 2023

42

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Nuclear binding of estrogen-receptor complex: receptor-specific nuclear acceptor sites

4 December 2023

43

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

DNA binding specificity of steroid receptors.

4 December 2023

44

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex

4 December 2023

46

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

A single-stranded DNA-binding protein promotes the binding of the purified oestrogen receptor to its responsive element

4 December 2023

47

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptor binding to a DNA response element in vitro is not dependent upon estradiol

4 December 2023

48

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Uterine estrogen receptor interaction with estrogen-responsive DNA sequences in vitro: effects of ligand binding on receptor-DNA complexes

4 December 2023

49

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cloning of a human gene encoding the general transcription initiation factor IIB

4 December 2023

50

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Five intermediate complexes in transcription initiation by RNA polymerase II

4 December 2023

51

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Expression of estrogen receptor and its messenger ribonucleic acid in the MCF-7 cell line: multiparametric analysis of its processing and regulation by estrogen

4 December 2023

54

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Ligand-Modulated Regulation of Progesterone Receptor Messenger Ribonucleic Acid and Protein in Human Breast Cancer Cell Lines

4 December 2023

55

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels

4 December 2023

56

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens

4 December 2023

57

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

A secreted glycoprotein induced by estrogen in human breast cancer cell lines

4 December 2023

62

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells

4 December 2023

63

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The N-terminal region of the chicken progesterone receptor specifies target gene activation

4 December 2023

64

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Characterization of estrogen responsive transforming activity in human breast cancer cell lines

4 December 2023

65

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells

4 December 2023

66

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Melatonin-induced increase in cytoplasmic estrogen receptor activity in hamster uteri

4 December 2023

68

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Melatonin increases oestrogen receptor binding activity of human breast cancer cells

4 December 2023

69

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells

4 December 2023

70

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Progestin regulation of estrogen receptor messenger RNA in human breast cancer cells

4 December 2023

72

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites

4 December 2023

75

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Mechanism of the estrogen receptor interaction with 4-hydroxytamoxifen

4 December 2023

76

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA

4 December 2023

78

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Purification of T47D human progesterone receptor and immunochemical characterization with monoclonal antibodies

4 December 2023

79

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Multiple Human Progesterone Receptor Messenger Ribonucleic Acids and Their Autoregulation by Progestin Agonists and Antagonists in Breast Cancer Cells

4 December 2023

80

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation

4 December 2023

82

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Progestin inhibition of progesterone receptor gene expression in human breast cancer cells

4 December 2023

84

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Mechanism of action of the sex steroid hormones (first of three parts).

4 December 2023

85

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The structure and function of progesterone receptors in breast cancer

4 December 2023

87

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Dimerization of the chicken progesterone receptor in vitro can occur in the absence of hormone and DNA

4 December 2023

88

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein

4 December 2023

89

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Reconstitution of progesterone receptor with heat shock proteins

4 December 2023

90

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Interaction of the chicken progesterone receptor with heat shock protein (HSP) 90

4 December 2023

92

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Hormone-dependent regulation of chicken progesterone receptor deoxyribonucleic acid binding and phosphorylation

4 December 2023

93

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Molecular and cellular biology of mammalian progesterone receptors

4 December 2023

94

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid- and progesterone-specific effects are determined by differential expression of the respective hormone receptors

4 December 2023

96

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation

4 December 2023

97

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid hormone-dependent interaction of human progesterone receptor with its target enhancer element

4 December 2023

98

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B

4 December 2023

99

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid hormone receptors and the nucleus

4 December 2023

100

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Regional chromosomal assignment of the human glucocorticoid receptor gene to 5q31

4 December 2023

102

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Primary structure and expression of a functional human glucocorticoid receptor cDNA

4 December 2023

103

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product.

4 December 2023

104

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Regulation of glucocorticoid receptor activity

4 December 2023

105

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors

4 December 2023

107

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

In Vitro Model Systems for the Study of Hormone-Dependent Human Breast Cancer

4 December 2023

108

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture

4 December 2023

109

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The transformed glucocorticoid receptor has a lower steroid-binding affinity than the nontransformed receptor

4 December 2023

111

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms

4 December 2023

112

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Biochemistry, molecular biology, and physiology of the glucocorticoid receptor

4 December 2023

113

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The glucocorticoid receptor

4 December 2023

115

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Location of the second steroid-binding site on the glucocorticoid receptor

4 December 2023

119

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Two glucocorticoid binding sites on the human glucocorticoid receptor

4 December 2023

120

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA

4 December 2023

121

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Structural determinants of a glucocorticoid receptor recognition element

4 December 2023

123

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Efficient binding of glucocorticoid receptor to its responsive element requires a dimer and DNA flanking sequences

4 December 2023

125

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Affinity of interactions between human glucocorticoid receptors and DNA: at physiologic ionic strength, stable binding occurs only with DNAs containing partially symmetric glucocorticoid response elements

4 December 2023

126

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor

4 December 2023

127

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Many transcription factors interact synergistically with steroid receptors

4 December 2023

129

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The structure and function of steroid receptor proteins

4 December 2023

130

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription

4 December 2023

131

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene

4 December 2023

132

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Co-localization of elements required for phorbol ester stimulation and glucocorticoid repression of proliferin gene expression

4 December 2023

133

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer

4 December 2023

134

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Transcriptional inhibition by a glucocorticoid receptor-beta-galactosidase fusion protein.

4 December 2023

135

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Half-life of synovial cell collagenase mRNA is modulated by phorbol myristate acetate but not by all-trans-retinoic acid or dexamethasone

4 December 2023

136

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor

4 December 2023

138

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cloning, structure and expression of a cDNA encoding the human androgen receptor

4 December 2023

140

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cloning of Human Androgen Receptor Complementary DNA and Localization to the X Chromosome

4 December 2023

141

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors

4 December 2023

142

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors

4 December 2023

143

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Mechanism of androgen action: recent observations on the domain structure of androgen receptors and the induction of EGF-receptors by androgens in prostate tumor cells

4 December 2023

144

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The human androgen receptor: domain structure, genomic organization and regulation of expression.

4 December 2023

145

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The human androgen receptor is a 110 kDa protein

4 December 2023

146

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen down-regulation of androgen receptors in cultured human mammary cancer cells (MCF-7).

4 December 2023

148

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Characterization and expression of a cDNA encoding the human androgen receptor

4 December 2023

149

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Regulatory regions of androgen-responsive genes

4 December 2023

150

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor

4 December 2023

152

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation

4 December 2023

154

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus

4 December 2023

156

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen regulation by the long terminal repeat of mouse mammary tumor virus

4 December 2023

157

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Identification of androgen response elements in mouse mammary tumour virus and the rat prostate C3 gene

4 December 2023

158

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region.

4 December 2023

159

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Mutations in the hormone regulatory element of mouse mammary tumor virus differentially affect the response to progestins, androgens, and glucocorticoids

4 December 2023

160

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen receptor-binding regions of an androgen-responsive gene

4 December 2023

161

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The rat androgen receptor gene promoter

4 December 2023

162

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen induction of messenger RNA concentrations in mouse kidney is posttranscriptional

4 December 2023

163

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Effect of androgen on the transcription of rat prostatic binding protein genes

4 December 2023

164

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Autologous down-regulation of androgen receptor messenger ribonucleic acid

4 December 2023

165

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen regulation of cell proliferation and expression of viral sequences in mouse mammary tumour cells

4 December 2023

166

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells

4 December 2023

168

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

4 December 2023

169

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The erbB gene and the EGF receptor

4 December 2023

171

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Oncogenes, growth factors, and signal transduction

4 December 2023

173

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Receptors for epidermal growth factor and other polypeptide mitogens

4 December 2023

174

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Expression of Transforming Growth Factor α (TGFα) in Differentiated Rat Mammary Tumors: Estrogen Induction of TGFα Production

4 December 2023

175

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors

4 December 2023

179

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Stimulation of mammary carcinoma cell proliferation by epithelial growth factor in vitro

4 December 2023

181

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Growth factor- and cyclic nucleotide-induced proliferation of normal and malignant mammary epithelial cells in primary culture

4 December 2023

182

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor requirement for development of cultured mammary gland

4 December 2023

183

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor stimulates cell proliferation and inhibits functional differentiation of mouse mammary epithelial cells in culture

4 December 2023

185

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor stimulation of human breast cancer cells in culture

4 December 2023

186

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture

4 December 2023

187

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture

4 December 2023

188

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein

4 December 2023

189

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade

4 December 2023

191

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

4 December 2023

192

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins

4 December 2023

193

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Regulation of epidermal growth factor-receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7

4 December 2023

194

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Regulation of high- and low-affinity epidermal growth factor receptors by glucocorticoids

4 December 2023

197

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The receptors for prolactin and growth hormone are localized in the same region of human chromosome 5

4 December 2023

200

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Identification and sequence analysis of a second form of prolactin receptor by molecular cloning of complementary DNA from rabbit mammary gland

4 December 2023

201

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family

4 December 2023

202

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Purification and partial sequence of the rabbit mammary gland prolactin receptor.

4 December 2023

203

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells

4 December 2023

204

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Expression of multiple forms of the prolactin receptor in mouse liver

4 December 2023

205

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Characterization and applications of monoclonal antibodies to the prolactin receptor

4 December 2023

206

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Immunological recognition of the prolactin receptor: identification of a single binding unit of molecular weight approximately 42,000.

4 December 2023

207

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Micromethod for the determination of free and total prolactin receptors: measurement of receptor levels in normal and malignant mammary and prostate tissues

4 December 2023

208

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Immunocytochemical and autoradiographic demonstration of prolactin binding to human breast cancer cells in tissue culture

4 December 2023

209

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Characterization of prolactin receptors in human breast cancer

4 December 2023

212

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Correlation between prolactin receptors (PRL R), estradiol (ER) and progesterone receptors (PgR) in human breast cancer

4 December 2023

213

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation

4 December 2023

214

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prolactin and murine mammary tumorigenesis: a review

4 December 2023

216

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture

4 December 2023

217

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prolactin Regulation of Casein Gene Expression: Possible Mediators*

4 December 2023

218

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression

4 December 2023

219

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Multiple regulation of prolactin receptor gene expression in rat liver.

4 December 2023

220

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer

4 December 2023

223

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: A multivariate analysis approach

4 December 2023

224

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer

4 December 2023

226

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma

4 December 2023

227

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer

4 December 2023

228

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer

4 December 2023

229

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies

4 December 2023

230

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid peptide hormone levels

4 December 2023

231

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

4 December 2023

232

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. A sequential multivariate analysis of 1262 patients

4 December 2023

233

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer

4 December 2023

234

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study

4 December 2023

235

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prognostic significance of oestrogen and progestogen receptor activities in breast cancer.

4 December 2023

236

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The histopathological evaluation of human breast cancers in correlation with estrogen receptor values

4 December 2023

237

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer

4 December 2023

238

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptors and prognosis in operable (stage I and II) breast cancer

4 December 2023

239

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up

4 December 2023

240

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group

4 December 2023

241

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptor levels in breast cancer. Relationships with age and menopausal status

4 December 2023

242

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer

4 December 2023

244

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

A multifactorial analysis of steroid hormone receptors in stages I and II breast cancer

4 December 2023

245

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences

4 December 2023

246

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The effect of age on estrogen and progesterone receptor in primary breast cancer

4 December 2023

247

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Changes in estrogen and progesterone receptor content of primary breast carcinoma during the menstrual cycle

4 December 2023

248

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

A comparison of estrogen and progesterone receptors in black and white breast cancer patients

4 December 2023

250

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Hormonal and personal effects on estrogen receptors in breast cancer

4 December 2023

253

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status

4 December 2023

254

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The interaction of estrogen receptor status and race in predicting prognosis for stage I breast cancer patients

4 December 2023

256

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Hormone receptors in rapidly progressing breast cancer

4 December 2023

257

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Progesterone and Oestrogen Receptors in Human Breast Cancer

4 December 2023

258

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Quantitative estrogen receptor values and growth of carcinoma of the breast before surgical intervention

4 December 2023

260

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer

4 December 2023

261

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Relationship of oestrogen-receptor status to survival in breast cancer

4 December 2023

262

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Correlation of hormone receptors with pathological features in human breast cancer

4 December 2023

263

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptors in early breast cancer: Value in prognosis

4 December 2023

264

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability

4 December 2023

265

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Pathological review of breast lesions analyzed for estrogen receptor protein

4 December 2023

266

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry

4 December 2023

267

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Correlation between nuclear cytomorphometric parameters and estrogen receptor levels in breast cancer

4 December 2023

268

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells

4 December 2023

269

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Relationship of cytosolic estrogen and progesterone receptor content and the growth fraction in human mammary carcinomas

4 December 2023

270

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease.

4 December 2023

271

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Relationship between flow cytometric parameters, steroid receptors, and menopausal status in breast cancers

4 December 2023

272

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Oestrogen receptor activity in intraduct and invasive breast carcinomas

4 December 2023

273

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Breast carcinoma cellularity and its relation to oestrogen receptor content

4 December 2023

274

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Simultaneous and sequential determinations of steroid hormone receptors in human breast cancer. Influence of intervening therapy

4 December 2023

275

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Pathologic findings from the national surgical adjuvant breast project. Correlations with concordant and discordant estrogen and progesterone receptors

4 December 2023

276

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Value of measuring hormone receptor levels of regional metastatic carcinoma of the breast

4 December 2023

277

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptor content of primary and secondary breast carcinoma: influence of time and treatment

4 December 2023

278

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The relationship between estrogen receptors in primary and secondary breast carcinomas and in sequential primary breast carcinomas

4 December 2023

279

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptors in bilateral breast cancer

4 December 2023

280

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptors and other prognostic factors in primary breast cancer

4 December 2023

281

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients

4 December 2023

282

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Influence of estrogen receptors on survival and recurrence in patients with breast cancer without lymph node metastases

4 December 2023

283

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients

4 December 2023

284

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group

4 December 2023

285

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading

4 December 2023

286

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The prognostic role of progesterone receptor status and age in relation to axillary node status in breast cancer patients

4 December 2023

287

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases

4 December 2023

288

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer

4 December 2023

289

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptor assay in primary breast cancer and early recurrence of the disease

4 December 2023

290

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Relationship between primary breast tumor receptor status and patient survival

4 December 2023

291

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Progesterone receptors as a prognostic factor in Stage II breast cancer

4 December 2023

292

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence

4 December 2023

294

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Response to tamoxifen in estrogen receptor-poor metastatic breast cancer

4 December 2023

295

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Selection of hormone-responsive advanced breast cancer with a cytoplasmic estrogen receptor assay. Analysis of 100 cases

4 December 2023

296

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The value of estrogen and progesterone receptors in the treatment of breast cancer

4 December 2023

297

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer

4 December 2023

299

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Relationship of quantitative estrogen-receptor level and clinical response to cytotoxic chemotherapy in advanced breast cancer. An extramural analysis

4 December 2023

300

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Differential response to chemotherapy in metastatic breast cancer in relation to estrogen receptor level. Results of a prospective randomized study

4 December 2023

301

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer

4 December 2023

302

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer

4 December 2023

305

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

4 December 2023

306

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer

4 December 2023

308

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer

4 December 2023

309

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Treatment of primary breast cancer with chemotherapy and tamoxifen

4 December 2023

310

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prognostic significance of estrogen and progesterone receptors in stage II breast cancer

4 December 2023

311

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The influence of hormone receptors and hormonal adjuvant therapy on disease-free survival in breast cancer: a multifactorial analysis

4 December 2023

312

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary report

4 December 2023

313

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptor in human breast cancer

4 December 2023

314

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: relationship to estrogen receptor and lymphatic invasion

4 December 2023

315

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance.

4 December 2023

316

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Receptors for epidermal growth factor and steroid hormones in human breast cancer

4 December 2023

317

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancer. EGF receptors and factors in gynecological carcinomas

4 December 2023

318

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptor status of histological sub-types of breast cancer

4 December 2023

319

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer

4 December 2023

320

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Receptors for epidermal growth factor in human mammary carcinomas and their metastases

4 December 2023

321

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Receptors for EGF and oestradiol and thymidinekinase activity in different histological subgroups of human mammary carcinomas

4 December 2023

322

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptors in human breast cancer

4 December 2023

323

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors

4 December 2023

324

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptor in human breast cancers: Correlation with estrogen and progesterone receptors

4 December 2023

325

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prognostic value of epidermal growth factor receptor in node-positive breast cancer

4 December 2023

326

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estimation of epidermal growth factor receptor in 177 breast cancers: correlation with prognostic factors

4 December 2023

327

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptor in human breast cancer: correlation with cytosolic and nuclear ER receptors and with biological and histological tumor characteristics

4 December 2023

328

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer

4 December 2023

330

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas

4 December 2023

331

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Expression of epidermal growth factor receptor in breast carcinoma

4 December 2023

332

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer

4 December 2023

333

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement

4 December 2023

334

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer

4 December 2023

335

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression

4 December 2023

336

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup

4 December 2023

337

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer

4 December 2023

339

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer

4 December 2023

341

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Heterogeneity and progesterone-receptor distribution in endometrial adenocarcinoma

4 December 2023

343

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Immunocytochemical assay of estrogen receptors in endometrial carcinoma with monoclonal antibodies. Comparison with biochemical assay

4 December 2023

344

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The distribution and prognostic implications of steroid receptors in endometrial carcinomas

4 December 2023

345

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Histologic composition of endometrial carcinomas analyzed for steroid receptor content

4 December 2023

346

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cytosol estrogen and progestin receptors in endometrial carcinoma of patients treated with surgery, radiotherapy, and progestin. Clinical correlates

4 December 2023

347

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Female sex steroid receptors in postmenopausal endometrial carcinoma and biochemical response to an antiestrogen

4 December 2023

348

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid hormone receptors in adenocarcinoma of the endometrium

4 December 2023

349

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The relationship of histologic and histochemical parameters to progesterone receptor status in endometrial adenocarcinomas

4 December 2023

350

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications

4 December 2023

351

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium

4 December 2023

352

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Tamoxifen and endometrial carcinoma: Alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia

4 December 2023

353

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Correlation of female sex steroid hormone receptors with histologic and ultrastructural differentiation in adenocarcinoma of the endometrium

4 December 2023

354

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance

4 December 2023

355

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Multiple steroid hormone receptors in normal and abnormal human endometrium

4 December 2023

356

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Heterogeneity in hormone receptor status in primary and metastatic endometrial cancer

4 December 2023

357

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma

4 December 2023

359

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Endometrial adenocarcinoma estrogen receptor content: association of clinicopathologic features with immunohistochemical analysis compared with standard biochemical methods

4 December 2023

360

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Correlation between cytoplasmic steroid receptors and tumour differentiation and invasion in endometrial carcinoma

4 December 2023

361

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma

4 December 2023

362

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Female sex steroid receptors in gynecological malignancies: clinical correlates

4 December 2023

363

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Progesterone binding in human endometrial carcinomas

4 December 2023

364

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Progesterone binding by human endometrial tissue during the proliferative and secretory phases of the menstrual cycle and by hyperplastic and carcinomatous endometrium

4 December 2023

365

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Do estrogen and progesterone receptors (E2R and PR) in metastasizing endometrial cancers predict the response to gestagen therapy?

4 December 2023

366

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

In vitro binding of progesterone by the human endometrium during the menstrual cycle and by hyperplastic, atrophic, and carcinomatous endometrium

4 December 2023

367

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Immunohistochemical Evaluation of Estrogen and Progesterone Receptor Content in 183 Patients with Endometrial Carcinoma: Part I: Clinical and Histologic Correlations

4 December 2023

368

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Are the histological and ultrastructural features of endometrial carcinomas reliable indicators of their steroid receptor content?

4 December 2023

369

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Endometrial adenocarcinoma. A multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors

4 December 2023

370

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma

4 December 2023

371

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer

4 December 2023

372

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer

4 December 2023

373

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Progesterone receptors in two groups of endometrial carcinoma

4 December 2023

375

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin therapy

4 December 2023

376

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The prognostic importance of steroid receptors in endometrial carcinoma

4 December 2023

378

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptors in human breast and endometrial carcinomas

4 December 2023

379

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Characterization of epidermal growth factor receptor in normal and neoplastic human endometrium

4 December 2023

380

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptor expression in normal and malignant endometrium

4 December 2023

381

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma

4 December 2023

383

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate

4 December 2023

385

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Treatment of advanced endomeprtrial adenocarcinoma with a combined cytotoxic therapy. Predictive value of cytosol estrogen and progestin receptor levels

4 December 2023

386

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Oestrogen and progestin receptors as prognostic indicators in endometrial cancer. A review of the literature

4 December 2023

387

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Clinical correlation of hormone receptor status in epithelial ovarian cancer

4 December 2023

388

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Importance of steroid receptors and aromatase activity in the prognosis of ovarian cancer: high tumor progesterone receptor levels correlate with longer survival

4 December 2023

389

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen receptor predominance in human ovarian carcinoma

4 December 2023

391

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estradiol and progesterone receptors in normal ovary and ovarian tumors

4 December 2023

392

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The relationship of steroid receptor expression to nuclear DNA distribution and clinicopathological characteristics in epithelial ovarian tumors

4 December 2023

393

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptor content in human ovarian tumors: survival of patients with ovarian carcinoma related to steroid receptor content

4 December 2023

394

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Correlation between Steroid Hormone Receptors, Histological and Clinical Parameters in Ovarian Carcinoma

4 December 2023

395

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptors in epithelial ovarian malignancies

4 December 2023

396

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptors in human ovarian malignancy. A review of four years tissue collection

4 December 2023

397

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cytoplasmic steroid receptors in ovarian tumours

4 December 2023

399

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen - and gestagen - receptors in ovarian carcinoma

4 December 2023

400

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptors in human ovarian tumors

4 December 2023

401

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

3H-estradiol and 3H-R5020 binding in cytosols of normal and neoplastic human ovarian tissue

4 December 2023

402

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen and oestrogen binding in cytosols of human ovarian tumours

4 December 2023

403

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor-like lesions of human ovary

4 December 2023

404

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Clinical significance of estrogen and progestin receptors in ovarian cancer

4 December 2023

406

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomas

4 December 2023

407

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary

4 December 2023

409

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptors in ovarian cancer

4 December 2023

410

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Clinical evaluation of steroid receptors in ovarian neoplasms

4 December 2023

412

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptors in ovarian neoplasms

4 December 2023

415

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptors in ovarian epithelial carcinoma

4 December 2023

416

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Ovarian carcinoma: histologic and clinical correlation of cytoplasmic estrogen and progesterone binding

4 December 2023

417

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progestin binding in cytosols of ovarian adenocarcinomas

4 December 2023

418

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptors and ovarian tumors: variation within primary tumors and between primary tumors and metastases

4 December 2023

420

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Survival of patients with ovarian cancer. Apart from stage and grade, tumor progesterone receptor content is a prognostic indicator.

4 December 2023

421

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The influence of estrogen and progesterone receptors on survival in patients with carcinoma of the uterine cervix

4 December 2023

422

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cytoplasmic estrogen receptors in carcinoma of the uterine cervix

4 December 2023

423

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cytosolic estrogen and progesterone receptors as prognostic parameters in stage IB cervical carcinoma

4 December 2023

424

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid hormone receptors in carcinoma of the cervix

4 December 2023

425

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prognostic importance of progesterone and estrogen receptors in cancer of the uterine cervix

4 December 2023

426

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Nuclear and "cytoplasmic" estrogen and progesterone receptors in squamous cell carcinoma of the cervix

4 December 2023

427

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptor expression in gynecological malignancies

4 December 2023

428

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix

4 December 2023

429

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid receptors in leukemia and lymphoma

4 December 2023

430

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid receptors in subpopulations of childhood acute lymphocytic leukemia

4 December 2023

432

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid receptors in immunological subtypes of childhood acute lymphocytic leukemia cells: a Pediatric Oncology Group Study

4 December 2023

433

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid receptors in childhood acute lymphocytic leukemia

4 December 2023

434

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid receptors in chronic lymphocytic leukemia.

4 December 2023

435

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid receptors, clinical characteristics, and implications for prognosis in chronic lymphocytic leukemia

4 December 2023

436

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsiveness

4 December 2023

437

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid receptors predict response to combination chemotherapy in patients with acute lymphoblastic leukemia

4 December 2023

442

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Impact of treatment efficacy on the prognostic value of glucocorticoid receptor levels in childhood acute lymphoblastic leukemia

4 December 2023

445

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen, estrogen and progestin binding sites in human leukemic cells

4 December 2023

447

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid receptor and in vitro sensitivity to steroid hormones in human lymphoproliferative diseases and myeloid leukemia

4 December 2023

448

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptor guideline for tamoxifen therapy in chronic lymphocytic leukemia: a pilot study

4 December 2023

451

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

In vitro glucocorticoid studies in human lymphoma: Clinical and biologic significance

4 December 2023

452

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid receptors and steroid sensitivity in normal and neoplastic human lymphoid tissues: a review

4 December 2023

453

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Characterization of a specific androgen receptor in non-Hodgkin's lymphoma cells

4 December 2023

454

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Correlation of histochemical and biochemical analyses of androgen binding in prostatic cancer: relation to therapeutic response

4 December 2023

456

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptor content in human prostatic carcinoma and response to endocrine therapy

4 December 2023

457

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Predicting response of prostatic carcinoma to endocrine therapy

4 December 2023

458

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progestin receptors in human prostatic carcinoma.

4 December 2023

460

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen receptors in cancer of the prostate. Correlation with the stage and grade of the tumor

4 December 2023

462

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen and oestrogen receptor status in benign and neoplastic prostate disease. Study of prevalence and influence on time to progression and survival in prostate cancer treated by hormone manipulation

4 December 2023

463

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen, estrogen, and progesterone receptor contents and serum hormone profiles in patients with benign hypertrophy and carcinoma of the prostate

4 December 2023

464

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen receptor binding activity in human prostate cancer

4 December 2023

466

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

A comparison of estrogen and androgen receptor levels in human prostatic tissue from patients with non-metastatic and metastatic carcinoma and benign prostatic hyperplasia

4 December 2023

467

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry

4 December 2023

468

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Characterization of androgen receptors in normal and malignant human prostatic tissues

4 December 2023

469

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour

4 December 2023

470

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen receptors detected by autoradiography in prostatic carcinoma and benign prostatic hyperplastic tissue

4 December 2023

472

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Relationship between concentrations of extractable and matrix-bound nuclear androgen receptor and clinical response to endocrine therapy for prostatic adenocarcinoma

4 December 2023

473

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Establishment of monoclonal antibody to human androgen receptor and its clinical application for prostatic cancers.

4 December 2023

474

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Relationship between androgen receptor binding activity in human prostate cancer and clinical response to endocrine therapy

4 December 2023

475

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Predicting the response of prostatic carcinoma to endocrine therapy

4 December 2023

476

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer

4 December 2023

477

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Determination of androgen, progestin and estrogen receptors with two different assays in renal cell carcinoma

4 December 2023

478

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid hormone receptors in normal and malignant human renal tissue: Relationship with progestin therapy

4 December 2023

479

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Nuclear androgen receptor as marker of responsiveness to medroxyprogesterone acetate in human renal cell carcinoma

4 December 2023

480

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptors in human renal carcinoma

4 December 2023

481

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Comparison of steroid receptor levels in renal-cell carcinoma and autologous normal kidney

4 December 2023

482

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Adjuvant medroxyprogesterone acetate and steroid hormone receptors in category M0 renal cell carcinoma. An interim report of a prospective randomized study

4 December 2023

483

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptors in renal carcinoma

4 December 2023

484

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Hormone receptors in renal cell carcinoma. Their utility as predictors of response to endocrine therapy

4 December 2023

485

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The endocrine background of human renal cell carcinoma. IV. Glucocorticoid receptors as possible mediators of progestogen action

4 December 2023

486

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The endocrine background of human renal cell carcinoma. I. Binding of the highly potent progestin R 5020 by tumour cytosol

4 December 2023

487

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Oestrogen-binding components in human renal cell carcinoma

4 December 2023

488

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Hormonal status of patients with primary malignant melanoma: a review of 313 cases

4 December 2023

489

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptors in melanoma metastases with special reference to analytical methods and prognosis

4 December 2023

490

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid hormone receptors in human melanoma

4 December 2023

491

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Immunofluorescent detection of hormone receptors in cutaneous melanocytic tumours

4 December 2023

492

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptors and tamoxifen in malignant melanoma

4 December 2023

493

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Incidence of estrogen receptor in benign nevi and human malignant melanoma

4 December 2023

494

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Oestrogen receptors in human malignant melanoma

4 December 2023

495

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Oestrogen and androgen receptors in melanoma

4 December 2023

496

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptors in patients with malignant melanoma

4 December 2023

497

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptor in malignant melanoma.

4 December 2023

498

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Sex steroid receptor analysis in human melanoma

4 December 2023

500

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptors in primary cutaneous melanoma

4 December 2023

501

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptor in malignant melanoma: Fact or artefact?

4 December 2023

502

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Endocrine treatment with anti-estrogen, anti-androgen or progestagen of advanced malignant melanoma: three consecutive phase II trials

4 December 2023

503

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptors in different skin tumors.

4 December 2023

505

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Sex steroid receptor distribution in the human larynx and laryngeal carcinoma

4 December 2023

506

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and Progesterone Receptors in Head and Neck Cancer

4 December 2023

507

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptors in normal salivary gland and salivary gland carcinoma

4 December 2023

508

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen Receptors in Laryngeal Carcinoma

4 December 2023

509

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estradiol Receptor-binding Protein in Head and Neck Neoplastic and Normal Tissue

4 December 2023

510

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cytoplasmic steroid receptors in cancer of the larynx

4 December 2023

511

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen receptors in normal and neoplastic laryngeal tissue

4 December 2023

512

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid hormone receptors in human salivary gland tumours

4 December 2023

513

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cytosolic and nuclear androgen receptor activity in the cancer of the larynx

4 December 2023

514

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen receptors and antiandrogen therapy for laryngeal carcinoma

4 December 2023

515

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid hormone receptors in laryngeal carcinoma

4 December 2023

516

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen receptors in laryngeal carcinoma

4 December 2023

517

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors

4 December 2023

518

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Increased EGF receptors on human squamous carcinoma cell lines

4 December 2023

519

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

TGF-alpha and EGF-receptor mRNAs in human oral cancers.

4 December 2023

520

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck

4 December 2023

522

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptors in human lung cancer

4 December 2023

523

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen receptors, androgen-dependent proliferation, and 5 alpha-reductase activity of small-cell lung cancer cell lines

4 December 2023

524

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid receptors in human tumors

4 December 2023

525

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Sex steroid receptors in diverse human tumors

4 December 2023

526

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptors in human lung cancer cytosols

4 December 2023

527

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptor expression in human lung cancer cell lines

4 December 2023

528

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Expression of epidermal growth factor receptor (EGF-R) in human lung tumours

4 December 2023

529

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Expression of epidermal growth factor receptors in four histologic cell types of lung cancer

4 December 2023

530

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival

4 December 2023

531

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptors in cancer tissues of esophagus, lung, pancreas, colorectum, breast and stomach

4 December 2023

532

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Expression of epidermal growth factor receptors in human lung tumors

4 December 2023

533

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Distribution of steroid hormone receptors in human soft tissue sarcomas

4 December 2023

535

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Increased cytosol glucocorticoid receptor content of leiomyosarcoma

4 December 2023

536

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptors in uterine sarcomas

4 December 2023

537

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas

4 December 2023

538

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estradiol and progesterone receptors in gynecologic sarcomas

4 December 2023

539

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptors in sarcomatous lesions

4 December 2023

540

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptor proteins in diverse human tumors

4 December 2023

541

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Evidence for increased epidermal growth factor receptors in human sarcomas

4 December 2023

542

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells

4 December 2023

543

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Sex hormone receptors in gastric cancer

4 December 2023

544

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progesterone receptors in gastric cancer

4 December 2023

545

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptors in gastric adenocarcinoma: a retrospective immunohistochemical analysis

4 December 2023

546

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

The effect of tamoxifen and estrogen receptor status on survival in gastric carcinoma

4 December 2023

547

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma

4 December 2023

549

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma

4 December 2023

550

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen receptor protein in adenomas of the large bowel

4 December 2023

552

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen receptors in colorectal adenomas

4 December 2023

553

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Sex steroid and 1,25-dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normal mucosa

4 December 2023

555

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Colonic neoplasms: tissue estrogen receptor and carcinoembryonic antigen

4 December 2023

556

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen and progesterone receptors in colonic and rectal cancers

4 December 2023

557

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen Receptors in Colorectal Adenocarcinomas and in Other Large Bowel Diseases

4 December 2023

558

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Oestrogen receptors in colorectal carcinoma

4 December 2023

559

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid hormone receptors in human colon cancers

4 December 2023

560

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Estrogen and progestin receptors in colonic cancer?

4 December 2023

561

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptors and the distribution of IR-carcinoembryonic antigen in colonic cancer

4 December 2023

562

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Steroid receptor pattern of human colorectal neoplasms

4 December 2023

563

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptors in colorectal carcinoma

4 December 2023

564

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Epidermal growth factor receptor expression in colorectal cancer

4 December 2023

565

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Oestradiol binding activity in rat liver tumours and in human hepatocellular carcinoma

4 December 2023

566

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Glucocorticoid receptors in hepatocellular carcinoma and adjacent liver tissue

4 December 2023

567

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women

4 December 2023

568

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Active uptake of testosterone by androgen receptors of hepatocellular carcinoma in humans

4 December 2023

569

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Ischemia effect on the level of steroid hormone receptors in hepatocellular carcinoma and adjacent liver tissue

4 December 2023

570

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Clinicopathologic comparisons between estrogen receptor-positive and -negative hepatocellular carcinomas

4 December 2023

571

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Amplification of the EGF receptor and c-myc genes in human esophageal cancers

4 December 2023

573

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas

4 December 2023

574

1 reference

https://api.crossref.org/works/10.1016/1040-8428(92)90086-6

4 December 2023

Identifiers

1 reference

7 August 2017

1 reference